Business Information
The group's principal activity is to discover, develop, manufacture and market pharmaceutical and health care products. It operates through three reportable segments, prescription pharmaceuticals, consumer health care and animal health. The prescription pharmaceuticals segment discovers, develops, manufactures and markets human ethical pharmaceutical products. The consumer health care segment develops, manufactures and markets over-the-counter, foot care and sun care products. The animal health segment discovers, develops, manufactures and markets animal health products. The group operates in Europe, Canada, Latin America, pacific area and Asia.
|
|
Name |
Title
|
Email
|
| Fred Hassan | Chmn., CEO | N/A | | Stanley Barshay | Chmn. - Consumer Health Care | N/A | | Mark Torii | Pres. - Schering, Plough Kabushiki Kaisha, Spkk | N/A | | Ismail Kola | Sr. VP - Discovery Research, Chief Scientific Officer | N/A | | Karl Salnoske | CIO, VP | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 10,594,000 | 1,143,000 | | 2005 | 9,508,000 | 269,000 | | 2004 | 8,272,000 | (947,000)
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
